Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids

Prime editing is a recently reported genome editing tool using a nickase-cas9 fused to a reverse transcriptase that directly synthesizes the desired edit at the target site. Here, we explore the use of prime editing in human organoids. Common TP53 mutations can be correctly modeled in human adult stem cell-derived colonic organoids with efficiencies up to 25% and up to 97% in hepatocyte organoids. Next, we functionally repaired the cystic fibrosis CFTR-F508del mutation and compared prime editing to CRISPR/Cas9-mediated homology-directed repair and adenine base editing on the CFTR-R785* mutation. Whole-genome sequencing of prime editing-repaired organoids revealed no detectable off-target effects. Despite encountering varying editing efficiencies and undesired mutations at the target site, these results underline the broad applicability of prime editing for modeling oncogenicmutations and showcase the potential clinical application of this technique, pending further optimization.

Automated summary

Prime editing is a novel genome editing tool that can successfully model various gene mutations in human organ systems, demonstrating its broad potential applications. Despite encountering issues with varying editing efficiencies and undesired mutations, prime editing-repaired organoids showed no detectable off-target effects.